Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference
Rhea-AI Summary
Chemed Corporation (NYSE: CHE) will present at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025 at ~2:00 p.m. ET at PGA National Resort in Palm Beach Gardens, Florida.
The presentation will be webcast live and presentation materials will be posted on Chemed's Investor Relations website at www.chemed.com. A replay will be available within 24 hours and accessible for 90 days. Chemed operates two subsidiaries, VITAS Healthcare and Roto-Rooter. Forward-looking statements in the release are subject to risks and may change; Chemed does not assume an obligation to update them.
Positive
- None.
Negative
- None.
News Market Reaction – CHE
On the day this news was published, CHE declined 0.36%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.
The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT:
Michael D. Witzeman
(513) 762-6714
FAQ
When will Chemed (CHE) present at the UBS 2025 Global Healthcare Conference?
How can investors watch Chemed's (CHE) UBS 2025 presentation live?
Will Chemed's (CHE) UBS 2025 presentation be available after the live event?
Where is the UBS 2025 Global Healthcare Conference presentation by Chemed (CHE) being held?
What subsidiaries does Chemed (CHE) operate that investors should know about?
Who can investors contact for more information about Chemed's (CHE) conference presentation?
